Friends of Cancer Research Search
Close

Type: Posters

Poster | SABCS 2024 | Agreement Across 10 Artificial Intelligence Models in Assessing HER2 in Breast Cancer Whole Slide Images: Findings from the Friends of Cancer Research Digital PATH Project

 | 

Poster | SITC 2024 | The Impact of Treatment Modalities on Use of ctDNA as an Early Endpoint in aNSCLC Trials

 | 

Poster | DIA 2024 | An Evaluation of PMRCs for Assessing Data in Racial and Ethnic Populations Underrepresented in Pivotal Trials Supporting Novel Oncology Approvals 2012-2023

 | 

   

Poster | 2018 SITC Annual Meeting | In Silico Assessment of Variation in TMB Quantification Across Diagnostic Platforms: Phase 1 of the Friends of Cancer Research Harmonization Project

 | 

Poster | 2019 ASCO Annual Meeting | TMB Standardization by Alignment to Reference Standards

 | 

Poster | 2022 ISLB Annual Congress | Collaborative Meta-analytical Approaches to Advance the Use of ctDNA in Clinical Cancer Research: The Friends of Cancer Research ctMoniTR Project

 | 

Poster | 2022 AMP Annual Meeting | Assessing Variability Across HRD Assays: Findings from the Friends’ HRD Harmonization Project

 | 

Poster | 2023 AACR Annual Meeting | Findings from the Friends of Cancer Research HRD Harmonization Project

 | 

Poster | 2023 ASCO Annual Meeting | Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets

 | 

Poster | 2023 ASCO Annual Meeting | Changes in ctDNA levels as an early indicator of outcomes in advanced NSCLC treated with TKI: Initial findings from a retrospective aggregate analysis of 8 clinical trials

 | 

1800 M Street NW, Suite 1050 South,
Washington, DC 20036
Phone: (202) 944-6700

Friends of Cancer Research is a 501 (C)(3) non-profit organization.
Our tax ID number is 52-1983273.

© Copyright 2025 Friends of Cancer Research. All rights reserved.

Linkedin X-twitter Youtube